Zeo ScientifiX 과거 수익 실적
과거 기준 확인 0/6
Zeo ScientifiX's earnings have been declining at an average annual rate of -0.3%, while the Biotechs industry saw earnings growing at 19% annually. Revenues have been growing at an average rate of 16.5% per year.
주요 정보
-0.3%
수익 성장률
14.3%
EPS 성장률
Biotechs 산업 성장 | 17.0% |
매출 성장률 | 16.5% |
자기자본 수익률 | n/a |
순이익 | -94.7% |
최근 수익 업데이트 | 31 Jul 2024 |
최근 과거 실적 업데이트
업데이트 없음
Recent updates
수익 및 비용 분석
Zeo ScientifiX 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
---|---|---|---|---|
31 Jul 24 | 5 | -5 | 9 | 0 |
30 Apr 24 | 5 | -5 | 9 | 0 |
31 Jan 24 | 5 | -6 | 10 | 0 |
31 Oct 23 | 5 | -7 | 11 | 0 |
31 Jul 23 | 5 | -9 | 13 | 0 |
30 Apr 23 | 5 | -10 | 14 | 0 |
31 Jan 23 | 6 | -10 | 15 | 0 |
31 Oct 22 | 6 | -9 | 15 | 0 |
31 Jul 22 | 7 | -7 | 13 | 0 |
30 Apr 22 | 6 | -6 | 12 | -1 |
31 Jan 22 | 6 | -6 | 12 | 0 |
31 Oct 21 | 6 | -13 | 18 | 0 |
31 Jul 21 | 5 | -17 | 21 | 0 |
30 Apr 21 | 4 | -21 | 24 | 1 |
31 Jan 21 | 4 | -20 | 23 | 0 |
31 Oct 20 | 3 | -13 | 15 | 0 |
31 Jul 20 | 3 | -8 | 10 | 0 |
30 Apr 20 | 2 | -3 | 5 | 0 |
31 Jan 20 | 2 | -2 | 4 | 0 |
31 Oct 19 | 2 | -2 | 3 | 0 |
31 Jul 19 | 1 | -1 | 4 | 0 |
30 Apr 19 | 1 | -1 | 2 | 0 |
31 Jan 19 | 1 | -4 | 5 | 0 |
31 Oct 18 | 1 | -3 | 5 | 0 |
31 Jul 18 | 1 | -4 | 5 | 0 |
30 Apr 18 | 1 | -5 | 6 | 0 |
31 Jan 18 | 1 | -5 | 6 | 0 |
31 Oct 17 | 1 | -9 | 9 | 0 |
31 Jul 17 | 0 | -8 | 8 | 0 |
30 Apr 17 | 0 | -8 | 8 | 0 |
31 Jan 17 | 0 | -5 | 5 | 0 |
31 Oct 16 | 0 | -1 | 1 | 0 |
31 Jul 16 | 0 | -1 | 1 | 0 |
30 Apr 16 | 0 | -1 | 1 | 0 |
31 Jan 16 | 0 | -1 | 1 | 0 |
31 Oct 15 | 0 | -1 | 1 | 0 |
31 Jul 15 | 0 | 0 | 0 | 0 |
30 Apr 15 | 0 | 0 | 0 | 0 |
31 Jan 15 | 0 | 0 | 0 | 0 |
31 Oct 14 | 0 | 0 | 0 | 0 |
31 Jul 14 | 0 | 0 | 0 | 0 |
30 Apr 14 | 0 | 0 | 0 | 0 |
31 Jan 14 | 0 | 0 | 0 | 0 |
양질의 수익: ZEOX is currently unprofitable.
이익 마진 증가: ZEOX is currently unprofitable.
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: ZEOX is unprofitable, and losses have increased over the past 5 years at a rate of 0.3% per year.
성장 가속화: Unable to compare ZEOX's earnings growth over the past year to its 5-year average as it is currently unprofitable
수익 대 산업: ZEOX is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-2.3%).
자기자본 수익률
높은 ROE: ZEOX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.